Tagged with Digital

Switzerland Adrian Hunn of Swiss Medtech, shares insights into his role and the future of Switzerland’s medtech sector. He discusses the association’s focus on fostering innovation, navigating regulatory challenges, and promoting international collaboration to position Switzerland as a global leader. Hunn highlights key initiatives, such as supporting digital healthcare, sustainability efforts,…

Switzerland David Traub, General Manager of Novartis in its home country of Switzerland, reflects on his journey to Novartis, emphasizing the need for innovation in Swiss healthcare. He discusses challenges in access to innovative medicines and the importance of healthcare digitalization, calling for bold reforms. Traub aims to collaborate with stakeholders…

Mexico Carlos Escobar highlights his extensive career journey at Baxter/Vantive, emphasizing the company’s commitment to enhancing patient care through innovative technologies in Mexico and Latin America. He discusses the shift towards multi-organ support, the importance of digitalization in healthcare, and the need for a strong organizational culture to drive value.  …

Switzerland Daniel Weber of Boehringer Ingelheim Switzerland explores the company’s strategic initiatives and focus on innovation within the Swiss healthcare system. Weber emphasizes Boehringer Ingelheim’s long-term vision of transforming lives, its commitment to early diagnosis, and its expanding role in digital health.   Our purpose and strong pipeline are what truly…

Switzerland The Federal Office of Public Health (FOPH) is the body responsible for safeguarding public health in Switzerland, developing national health policies, and overseeing the Swiss healthcare system. In an exclusive conversation, FOPH Director Anne Lévy discusses the key challenges facing the Swiss healthcare system today and highlights potential solutions as…

Saudi Arabia Dr Mahmoud Alyamani, Health & Well-Being Sector Head at NEOM, the sustainable region taking shape in northwest Saudi Arabia. He discusses NEOM’s innovative healthcare vision, emphasizing a proactive, data-driven approach using digital twins and AI. He also highlights the importance of global partnerships to co-create advanced health solutions and NEOM’s…

Saudi Arabia aljeel, a leading Saudi family-owned medtech distributor, has undergone a structural transformation in recent years and today attempts to maintain the dynamism of a family business while incorporating the structured processes of a publicly traded entity. Now CEO of the firm, AbdulGhani El-Ajou touches on some of aljeel’s key initiatives,…

Global Oskar Möbert, vice president of Veeva OpenData, discusses how standardizing customer reference data and systems organization-wide can help biopharmas scale globally and become more agile in their business.   Data quality can make or break an interaction with a healthcare professional (HCP). Reps with access to accurate customer data deliver treatment…

Global As head of digital transformation at Bayer, Saskia Steinacker is well placed to unpack the hype around artificial intelligence in healthcare. In a wide-ranging interview, she explains how AI is already transforming the company’s internal processes and external impact, why stakeholders must not lose sight of solving real-world problems in…

Portugal From software development to sales and consultancy, Alexandre Leiria today heads up the Life Sciences, Healthcare, and Manufacturing arm of digital-focused consultancy Capgemini in Portugal. He discusses Capgemini’s role in advancing digital transformation in the Portuguese healthcare sector. Despite progress, challenges remain, such as the need for further investments and…

India Ayushman Bharat, launched in 2018, is a monumental scheme addressing the lack of healthcare accessibility and affordability for over 500 million people in India. Dr Indu Bhushan, Ayushman Bharat’s inaugural CEO, explains how the scheme was swiftly implemented, utilizing socio-economic caste census data to determine eligibility inclusively; how it reduces…

United Kingdom AstraZeneca has made a bold move by offering its in-house digital clinical trial expertise to clinical research organisations (CROs) and other pharmaceutical companies via the launch of healthtech business Evinova. AstraZeneca’s apparent willingness to share expertise with its competitors has raised some eyebrows, but the British firm is steadfast in…